Crispin Blunt

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the NHS Commercial Framework on access to medicines through managed access agreements.

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of establishing a new orphan medicines pathway at NICE to enable orphan medicines which do not qualify for the highly specialised technology eval...

To ask the Secretary of State for Health and Social Care, with reference to paragraph 3.21 of the 2019 voluntary scheme for branded medicines pricing and access, when NICE will review the process and methods for the highly specialised technology evaluatio...

To ask the Secretary of State for Health and Social Care, which medicinal products were made available on the NHS with a managed access agreement in (a) 2018-19 and (b) 2019 to date.

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the reasons why the Cancer Drugs Fund has been underspent; and if he will make a statement.

To ask the Secretary of State for Health and Social Care, what Cancer Drugs Fund expenditure cap is for (a) 2019-20 and (b) 2020-21.

To ask the Secretary of State for Foreign and Commonwealth Affairs, what assessment he has made of the implications for his policies of the ongoing judicial proceedings against women’s rights activists in Saudi Arabia; and whether UK officials have been g...

To ask the Secretary of State for the Home Department, how many Saudi citizens applied for asylum in the UK in (a) 2017, (b) 2018 and (c) 2019.

To ask the Secretary of State for Health and Social Care, whether the Human papillomavirus (HPV) vaccination status of the patient will be recorded under the new HPV primary screening programme.

To ask the Secretary of State for Health and Social Care, whether human papillomavirus screening is able to identify specific strains of that virus.

To ask the Secretary of State for Health and Social Care, what steps Public Health England plans to take to assess the effectiveness of the HPV vaccination programme.

To ask the Secretary of State for the Home Department, how many schedule 1 (a) domestic and (b) import licences cannabis and cannabis-based products were granted in 2019.

To ask the Secretary of State for Housing, Communities and Local Government, what steps his Department is taking to ensure that local planning authorities reject planning applications which do not comply with the guidance set out in (a) the National Desig...

To ask the Secretary of State for Housing, Communities and Local Government, whether the proposed White Paper on planning will include guidance on the benefits of designing (a) higher density developments and (b) highways that are sensitive to their surro...

To ask the Secretary of State for Housing, Communities and Local Government, if he will make an assessment of the implications for his policies on housing developments of the Campaign to Protect Rural England report titled, A housing design audit for Engl...

To ask the Secretary of State for the Home Department, how many (a) high-THC cultivation licences, (b) low-THC cultivation licences, (c) Schedule 1 domestic licences and (d) Schedule 1 import licences were granted in 2019.

To ask the Secretary of State for Health and Social Care, whether there are circumstances under which Specialist Importers may import cannabis-based active pharmaceutical ingredients for use in the manufacturing of cannabis-based products for medicinal us...

To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency has assessed the (a) safety and (b) quality of unlicensed cannabis-based products for medicinal use.

To ask the Secretary of State for Health and Social Care, how many notifications the Medicines and Healthcare products Regulatory Agency has received from (a) pharmacies and (b) Specialist Importers on importation orders for unlicensed cannabis-based prod...

To ask the Secretary of State for Health and Social Care, whether there are circumstances under which Specialist Importers of cannabis-based products for medicinal use are permitted to import that product in bulk.